NewCardio, Inc.
NWCI · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Revenue | $10 | $102 | $39 | $88 |
| % Growth | -90.3% | 159.9% | -55.6% | – |
| Cost of Goods Sold | $27 | $36 | $62 | $68 |
| Gross Profit | -$18 | $66 | -$23 | $20 |
| % Margin | -177.9% | 64.6% | -58% | 23% |
| R&D Expenses | $566 | $693 | $725 | $911 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $962 | $1,096 | $1,210 | $1,184 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $12 | $12 | $12 | $4 |
| Operating Expenses | $1,541 | $1,800 | $1,947 | $2,099 |
| Operating Income | -$1,558 | -$1,734 | -$1,970 | -$2,079 |
| % Margin | -15,764.4% | -1,707.4% | -5,042.4% | -2,360.6% |
| Other Income/Exp. Net | -$721 | $799 | -$445 | -$1,043 |
| Pre-Tax Income | -$2,279 | -$935 | -$2,415 | -$3,121 |
| Tax Expense | $0 | $0 | $0 | $1,133 |
| Net Income | -$2,279 | -$935 | -$2,415 | -$3,211 |
| % Margin | -23,059.8% | -920.6% | -6,181.4% | -3,645.9% |
| EPS | -0.07 | -0.029 | -0.08 | -0.11 |
| % Growth | -141.4% | 63.8% | 27.3% | – |
| EPS Diluted | -0.07 | -0.029 | -0.08 | -0.11 |
| Weighted Avg Shares Out | 32,572 | 32,228 | 30,742 | 28,638 |
| Weighted Avg Shares Out Dil | 32,572 | 32,228 | 30,742 | 28,638 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $120 | $109 | $95 | $90 |
| Depreciation & Amortization | $20 | $20 | $21 | $21 |
| EBITDA | -$2,139 | -$806 | -$2,299 | -$2,058 |
| % Margin | -21,643.2% | -793.6% | -5,884.5% | -2,336.8% |